Pylarify

Ended Awarded Last action

Contract number
36C26224F0081
Awardee
Awarding agency
Obligated
$1,466,705

Award facts

Contract value 100% obligated
$1,466,705.44 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
North Billerica, Billerica, MA 01862, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00003 $47,305
Supplemental Agreement for work within scope P00002 -$396,959
Other Administrative Action P00001 $0
Original award $1,816,360

About this award

This is a firm fixed-price delivery order contract awarded to Progenics Pharmaceuticals Inc., a subsidiary of Lantheus Holdings, Inc., by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 22. The contract, valued at $1,466,705.44, is for the delivery of PYLARIFY (piflufolastat F-18), a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect, localize, and image prostate cancer. The contract has an ultimate completion date of October 31, 2024 and is not set aside for small businesses. Progenics Pharmaceuticals is the prime contractor and holds several Indefinite Delivery Vehicles (IDVs), including Blanket Purchase Agreements (BPAs) with the VA and Defense Health Agency, to facilitate the ongoing procurement of PYLARIFY and other radiopharmaceuticals for federal healthcare programs.

Quick answers

Who was awarded contract 36C26224F0081?

36C26224F0081 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 22 (Veterans Health Administration) on November 1, 2023.

How much is contract 36C26224F0081 worth?

The government has obligated $1,466,705 on 36C26224F0081.

Is contract 36C26224F0081 an order under another contract?

Yes. 36C26224F0081 is a delivery order under 36F79719D0170, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26224F0081 competed?

The extent of competition for 36C26224F0081 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award